Novartis invests $55m in US gene therapy site, prepares BLA
AveXis – a Novartis company – has added a manufacturing facility in North Carolina to its site network, where it will make investigational therapies for neurological genetic diseases.
Archives for June 1, 2018
NEWS IN BRIEF
US FDA pauses CRISPR gene-edited therapy trial for sickle cell disease
The US FDA has placed CRISPR Technologies and Vertex Pharmaceuticals’ investigational stem cell treatment on clinical hold.
CMO Rentschler signs Ultragenyx fill/finish deal for US supply
Ultragenyx Pharmaceutical is transferring fill/finish activities for Mepsevvi from Rentschler Biopharma’s facility in Germany, to Rentschler Fill Solutions in Austria.